This Government Contract opportunity from Department Of Defense was posted on May 15, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Lead Candidate Selection and Compound Characterization

Closed

Federal

Submission Closed05/25/2026, 09:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541711

New

Federal

Engineering & Scientific Research SupportThe contract entails providing engineering analysis, research and development, and technical support specifically focused on F-15 aircraft systems, encompassing avionics, propulsion, and weapons integration. The work involves activities such as modeling, simulation, and the formulation of test plans to support enhancements and maintenance of these complex systems. Issued by the Department of Defense under the NAICS code 541711, this subcontract titled "Engineering & Scientific Research Support" is designed to advance the technical capabilities and reliability of the F-15 platform. While certain logistical details like the exact place of performance and point of contact are not specified, the contract underscores a commitment to rigorous scientific and engineering efforts to ensure mission readiness and technological superiority for this key military asset.

FA8622 Aflcmc Azs Epass

POSTED

DEADLINE

Biomanufacturing Process DevelopmentThis contract focuses on the development of biomanufacturing processes to support scalable biological systems aimed at advancing medical countermeasures, synthetic biology, and bio-based materials specifically for defense applications. It is a subcontract opportunity issued by the Department of the Army under the Department of Defense, targeting expertise in process development within these cutting-edge biological fields to enhance capabilities in defense-related biotechnologies. The solicitation was posted on June 8, 2026, and interested parties must submit their responses by August 11, 2026. Categorized under the NAICS code 541711, which pertains to research and development in physical, engineering, and life sciences, this contract does not specify set-aside provisions or particular organization types. While precise performance locations and points of contact are not disclosed, the emphasis is clearly on advancing scalable and innovative biomanufacturing methods that will support defense objectives through the integration of synthetic biology and bio-based materials.

Department Of The Army -- Materiel Command

POSTED

DEADLINE

Non-Optical Signal Integration (Magnetic/Focused Ultrasound)The contract focuses on the development and integration of protein domains with magnetic fields or focused ultrasound techniques to enable remote, real-time control of cellular functions. The key objectives emphasize ensuring that these modulation methods are biologically compatible, minimizing any off-target effects that could interfere with cellular processes. This initiative aims to advance non-optical signal integration technologies with applications potentially valuable to biomedical and defense sectors. Issued by the Defense Advanced Research Projects Agency under the Department of Defense, the work is categorized under NAICS code 541711, which pertains to research and development in the physical, engineering, and life sciences. The contract is a subcontract opportunity with a response deadline set for December 8, 2026. Although location specifics and points of contact were not provided, the project aligns with DARPA’s goals of pioneering innovative and high-impact research solutions.

Defense Advanced Research Projects Agcy

POSTED

DEADLINE

Basic Research in Physical and Biological SciencesThis contract focuses on conducting exploratory research across multiple scientific disciplines, including physics, chemistry, biology, neuroscience, and energy sciences, aimed at advancing future defense technologies. The research targets innovative areas such as bio-inspired materials and directed energy, which have potential applications in enhancing defense capabilities. The scope encompasses basic research to uncover new knowledge that could inform and improve defense systems. Issued by the Air Force Office of Scientific Research within the Department of Defense, this subcontract falls under NAICS code 541711, which pertains to research and development in physical, engineering, and life sciences. Although specific details regarding the place of performance and points of contact are not provided, the contract is positioned as a critical initiative to support long-term defense innovation by funding fundamental scientific investigations. The solicitation was posted on June 4, 2026, indicating a forward-looking investment in cutting-edge research fields relevant to national security.

Air Force Office Of Scientific Research

POSTED

DEADLINE

Clinical Trial Design and Execution (Phase 1)The contract involves the design and execution of Phase 1 clinical trials to evaluate the safety, appropriate dosage, and initial immunogenicity of pandemic influenza vaccine candidates in human subjects. It is a subcontract opportunity issued by the Department of Health and Human Services through the Barda division, with a focus on advancing vaccine development during a public health emergency. The solicitation was posted on June 3, 2026, with a response deadline set for July 15, 2026. The work is to be performed in Washington, DC, under the NAICS code 541711, which pertains to research and development in biotechnology. The contract emphasizes the early-stage clinical evaluation critical to moving pandemic influenza vaccines forward toward regulatory approval and widespread use.

Barda - Aspr / Daappo / Barda Dcma

POSTED

14 days ago

DEADLINE

in 29 days

AI Contract Overview

This contract involves conducting in vitro screening and biochemical characterization of cap-dependent endonuclease inhibitors with the goal of identifying lead compounds effective against bunyaviruses and arenaviruses. The work will also include structure-activity relationship (SAR) analysis to understand how chemical modifications impact the inhibitors' activity, alongside efforts to optimize their pharmacological properties to improve efficacy and safety profiles. The overall objective is to select promising candidate compounds for further development in antiviral research. The contract is classified under NAICS code 541711 and is issued as a subcontract by the Naval Supply Fleet Logistics Center in Norfolk, under the Department of Defense. The place of performance is stated as Galveston. The posting date for this opportunity was May 15, 2026, with a response deadline of May 25, 2026. This reflects a focused initiative to advance therapeutic agents targeting viral pathogens relevant to defense and public health.

General Info

In vitro screening and SAR analysis of endonuclease inhibitors targeting bunyaviruses and arenaviruses.

Agency

Department Of Defense → Navsup Flt Logistics Ctr Norfolk

NAICS

541711View NAICS

Place of Performance

Galveston, TX, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed

PostedMay 15

subcontract

Response DeadlineMay 25

Deadline has passed

Submission Closed

05/25/2026, 09:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → Navsup Flt Logistics Ctr Norfolk

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → Navsup Flt Logistics Ctr Norfolk

Office AddressN/A

ContactsNo contact information available

Full Description

Conduct in vitro screening and biochemical characterization of cap-dependent endonuclease inhibitors (CENis) to identify lead candidates active against bunyaviruses and arenaviruses. Perform SAR analysis and optimize pharmacological properties.